KR102167153B1 - Powder manufacturing method that emits far-infrared rays - Google Patents
Powder manufacturing method that emits far-infrared rays Download PDFInfo
- Publication number
- KR102167153B1 KR102167153B1 KR1020200047534A KR20200047534A KR102167153B1 KR 102167153 B1 KR102167153 B1 KR 102167153B1 KR 1020200047534 A KR1020200047534 A KR 1020200047534A KR 20200047534 A KR20200047534 A KR 20200047534A KR 102167153 B1 KR102167153 B1 KR 102167153B1
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- weight
- parts
- infrared rays
- skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Abstract
Description
본 발명은 원적외선을 방출하는 파우더 제조방법에 관한 것으로, 보다 상세하게는 곰팡이 발생을 억제하면서 축산 사료 등에도 사용할 수 있어 용도 다변화가 가능한 원적외선을 방출하는 파우더 제조방법에 관한 것이다.The present invention relates to a method for producing a powder that emits far-infrared rays, and more particularly, to a method for producing a powder that emits far-infrared rays, which can be used in livestock feed while suppressing the occurrence of mold, and thus can be diversified in use.
피부의 진피층은 대다수의 타입 Ⅰ콜라겐과 약간의 타입 Ⅲ 콜라겐, 엘라스틴, 프로테오글리칸(proteoglycan), 피브로넥틴(fibronectin) 등으로 구성되어 있는데 피부가 만성적 일광손상을 입은 경우, 진피의 상부쪽 교원질에 비정상적인 엘라스토틱 물질이 침착되고, 프로테오글리칸(proteoglycan)이 증가되어 진피의 주 단백질인 콜라겐이 현저히 감소된다.The dermal layer of the skin is composed of the majority of type I collagen and some type Ⅲ collagen, elastin, proteoglycan, fibronectin, etc. If the skin suffers chronic sun damage, an abnormal elasto in the collagen on the upper part of the dermis Tick substances are deposited, proteoglycan is increased, and collagen, the main protein of the dermis, is significantly reduced.
이 경우, 콜라겐은 피부 섬유아세포에서 생성되는 주요 기질 단백질로서 세포외 간질에 존재하고, 생체 단백질 총중량의 30%를 차지하는 중요한 단백질로 견고한 3중 나선구조를 가지며, 주된 기능은 피부의 기계적 견고성, 결합조직의 저항력과 조직의 결합력, 세포접착의 지탱, 세포분할과 분화의 유도 등이 있으며, 특히 피부에 강도와 장력을 부여하여 외부 자극이나 힘으로부터 피부를 보호하는 역할을 한다.In this case, collagen, as a major matrix protein produced in skin fibroblasts, exists in the extracellular stroma, and is an important protein that accounts for 30% of the total weight of the biological protein, and has a solid triple helix structure. The main function is the mechanical firmness and binding of the skin. There are tissue resistance and binding force of tissues, support of cell adhesion, induction of cell division and differentiation, etc. In particular, it provides strength and tension to the skin to protect the skin from external stimuli or force.
이와 같이 진피층의 90%를 차지하고 있는 콜라겐의 감소는 피부의 노화와 매우 밀접한 관계를 가진다고 보고되어 있다.It has been reported that the decrease in collagen, which occupies 90% of the dermal layer, has a very close relationship with the aging of the skin.
그리고, 생체 내에서 콜라겐과 같은 세포외 기질의 합성과 분해는 적절하게 조절되나 노화가 진행되면서 그 합성은 감소되고, 콜라겐을 분해하는 효소인 기질 금속단백질 분해효소(matrix metalloproteinase, MMP)의 발현이 촉진되어 피부의 탄력이 저하되고 주름이 형성된다.In addition, the synthesis and decomposition of extracellular matrix such as collagen in vivo is properly regulated, but the synthesis is reduced as aging progresses, and the expression of matrix metalloproteinase (MMP), an enzyme that degrades collagen, is appropriately regulated. It is promoted to reduce the elasticity of the skin and form wrinkles.
이에 많은 화장료 조성물, 즉 화장품들이 출시되어 시판되고 있으나 효과가 전혀 없는 것은 아니지만 피부재생 능력이나 피부탄력 개선 능력이 눈에 띌 정도로 개선되지는 못하고 있다.Accordingly, many cosmetic compositions, that is, cosmetics, have been released and marketed, but they are not effective at all, but the skin regeneration ability or skin elasticity improvement ability has not been noticeably improved.
또한, 혈액순환 불균형은 피부트러블을 발생시키고 약화시키는 요인중 하나로 작용한다.In addition, imbalance in blood circulation acts as one of the factors that cause and weaken skin troubles.
본 발명은 상술한 바와 같은 종래 기술상의 제반 문제점들을 감안하여 이를 해결하고자 창출된 것으로, 곰팡이 발생을 억제하면서 축산 사료 등에도 사용할 수 있어 용도 다변화가 가능한 원적외선을 방출하는 파우더 제조방법을 제공함에 그 주된 목적이 있다.The present invention was created to solve the problems in the prior art as described above, and it is intended to provide a powder manufacturing method that emits far-infrared rays that can be used for livestock feed while suppressing the occurrence of mold and diversify its use. There is a purpose.
본 발명은 상기한 목적을 달성하기 위한 수단으로, 0.01-0.05㎛의 입도를 갖는 페그마타이트 분말 100중량부에 대해, 치아시드 추출물의 건조분말 10중량부, 게르마늄 분말 5중량부, 셀레늄 분말 10중량부, 지르코늄 분말 3.5중량부, 이트륨 분말 4.0중량부, 마그네슘 분말 6.5중량부를 포함하고; 상기 페그마타이트 분말 100중량부에 대해 잣 분말 10중량부와, DCHF-DA 분말 6.5중량부와, 케나프 추출물의 건조분말 8.5중량부가 더 첨가된 원적외선을 방출하는 파우더 제조방법에 있어서; 치아시드 추출물의 건조분말을 제외한 나머지 파우더 조성물을 혼합하는 제1단계; 혼합된 파우더 조성물에 바실러스 균액을 살포하고 상온(18-20℃)에서 48시간 자연숙성시키는 제2단계; 자연숙성이 완료되면 3eV의 전자선을 조사하여 남은 바실러스균을 완전히 살균하고, 동시에 건조하는 제3단계; 제3단계 후, 상기 제1단계에서 배제시켰던 치아시드 추출물의 건조분말을 계량분만큼 첨가 혼합하는 제4단계;를 포함하는 것을 특징으로 하는 원적외선을 방출하는 파우더 제조방법을 제공한다.The present invention is a means for achieving the above object, with respect to 100 parts by weight of pegmatite powder having a particle size of 0.01-0.05 μm, 10 parts by weight of dry powder of chia seed extract, 5 parts by weight of germanium powder, 10 parts by weight of selenium powder, 3.5 parts by weight of zirconium powder, 4.0 parts by weight of yttrium powder, and 6.5 parts by weight of magnesium powder; In the powder manufacturing method for emitting far-infrared rays to which 10 parts by weight of pine nut powder, 6.5 parts by weight of DCHF-DA powder, and 8.5 parts by weight of dry powder of kenaf extract are further added to 100 parts by weight of the pegmatite powder; A first step of mixing the remaining powder composition excluding the dry powder of chia seed extract; A second step of spraying the Bacillus bacteria solution on the mixed powder composition and naturally aging for 48 hours at room temperature (18-20°C); A third step of completely sterilizing the remaining Bacillus bacteria by irradiating an electron beam of 3 eV when natural aging is completed, and drying at the same time; After the third step, a fourth step of adding and mixing the dry powder of the chia seed extract excluded in the first step as much as the measured amount; provides a powder manufacturing method for emitting far-infrared rays, characterized in that it comprises.
본 발명에 따르면, 곰팡이 발생을 억제하면서 축산 사료 등에도 사용할 수 있어 용도 다변화가 가능한 효과를 얻을 수 있다.According to the present invention, it can be used for livestock feed, etc. while suppressing the occurrence of mold, and thus, it is possible to obtain an effect of diversifying uses.
이하에서는, 본 발명에 따른 바람직한 실시예를 보다 상세하게 설명하기로 한다.Hereinafter, a preferred embodiment according to the present invention will be described in more detail.
본 발명에 따른 원적외선을 방출하는 갖는 파우더는 비누를 비롯한 각종 화장품에 혼합 사용하도록 구성된다.The powder having far-infrared radiation according to the present invention is configured to be mixed and used in various cosmetics including soap.
물론, 비누 혹은 각종 화장품류에 따라 첨가되는 함량이 달라질 수 있지만, 기본적으로 본 발명에 따른 파우더는 혈액순환 촉진과 그에 따른 피부 흡수력 증진 및 항곰팡이성 강화 기능을 발현하도록 구성된다.Of course, the amount added may vary depending on soap or various cosmetics, but basically, the powder according to the present invention is configured to promote blood circulation, thereby enhancing skin absorption and enhancing anti-fungal properties.
즉, 본 발명에 따른 파우더는 0.01-0.05㎛의 입도를 갖는 페그마타이트 분말 100중량부에 대해, 치아시드 추출물의 건조분말 10중량부, 게르마늄 분말 5중량부, 셀레늄 분말 10중량부, 홀뮴 분말 5중량부, 지르코늄 분말 1.5중량부, 이트륨 분말 2.0중량부, 마그네슘 분말 10중량부를 포함한다.That is, the powder according to the present invention is based on 100 parts by weight of pegmatite powder having a particle size of 0.01-0.05 μm, 10 parts by weight of dry powder of chia seed extract, 5 parts by weight of germanium powder, 10 parts by weight of selenium powder, 5 parts by weight of holmium powder , 1.5 parts by weight of zirconium powder, 2.0 parts by weight of yttrium powder, and 10 parts by weight of magnesium powder.
특히, 본 발명에 따른 파우더는 전통장류에서 추출한 균주인 바실러스균에 의해 자연숙성되게 처리하여 비자극성을 갖도록 구성한 것이 특징이다.In particular, the powder according to the present invention is characterized in that it is naturally aged by Bacillus bacteria, which is a strain extracted from traditional paste, to have non-irritating properties.
이때, 자연숙성은 상온(18-20℃)에서 48시간 동안 유지되는 것을 말하고, 자연숙성 후 살균 건조하여 사용된다.At this time, natural aging means that it is maintained at room temperature (18-20°C) for 48 hours, and is used after sterilizing and drying after natural aging.
여기에서, 상기 페그마타이트 분말은 등록특허 제10-0366879호(2002.12.08.), '페그마타이트를 함유하는 인체 혈액 순환용 파우더 및 그 제조방법' 외 다수의 특허기술에서 혈액순환 촉진 기능이 입증된 분말 물질이다.Here, the pegmatite powder is a powder whose function of promoting blood circulation has been proven in a number of patented technologies such as Registration Patent No. 10-0366879 (2002.12.08.),'Pegmatite-containing powder for human blood circulation and its manufacturing method' It is a substance.
이러한 페크마타이트는 마그마의 분화 광상 생성물로서 거정질 화강암이라고도 불리며, 약리 작용을 할 수 있는 광석을 특히 거정석 페그마타이트라고 하는데 나노 에어 제트밀(미분쇄기)로 마쇄하여 미분 상태로 첨가된다.Such pekmatite is also called macrocrystalline granite as a product of the differentiation of magma, and an ore capable of pharmacological action is especially called macrocrystal pegmatite, and it is pulverized with a nano air jet mill (pulverizer) and added in a fine powder state.
페그마타이트는 단일 20종의 성분 중 인체에 유리한 9종의 성분을 함유한 광물질인 바, 단독 방사체의 소재로서 원적외선 방사 및 항균 탈취 기능을 가지며, 신체 접촉시 체내 세포 활성화와, 혈액 순환 촉진 기능을 하게 된다.Pegmatite is a mineral containing 9 components that are beneficial to the human body among 20 single components.As a material for a single radiator, it has far-infrared radiation and antibacterial and deodorizing functions, and when in contact with the body, it activates cells in the body and promotes blood circulation. do.
그리고, 치아시드 추출물의 건조분말은 천연식물인 치아시드(Chia Seed)에서 추출한 추출물을 건조시켜 만든 분말을 말한다.In addition, the dry powder of chia seed extract refers to a powder made by drying the extract extracted from the natural plant Chia Seed.
이 건조분말에는 리놀렌산(C18H30O2)이 다량 함유되기 때문에 천연 항균효과가 매우 우수하다. 특히, 자극은 없고 항균성은 우수한 무자극 천연 항균기능을 수행하게 된다.Since this dry powder contains a large amount of linolenic acid (C1 8 H 30 O 2 ), its natural antibacterial effect is very good. In particular, it performs a non-irritating natural antibacterial function with no stimulation and excellent antibacterial properties.
또한, 상기 게르마늄 분말은 피부 접촉시 전위 역전에 의한 통증완화력을 강화를 위해 첨가된다.In addition, the germanium powder is added to enhance pain relief by reversing potential upon skin contact.
예컨대, 통상 통증을 일으키는 부위는 전위가 높은데, 게르마늄의 경우 제일 바깥쪽 궤도(N각)에 32개의 전자가 들어가야 하지만 4개 밖에 없기 때문에 전자를 받아들이기 보다는 전자를 제공하여 결합하려는 성질이 강하다.For example, a site that causes pain usually has a high potential, but in the case of germanium, 32 electrons must enter the outermost orbit (N angle), but since there are only 4, it has a strong property to provide electrons and bind them rather than accepting electrons.
이와 같은 이유로 통증 부위에 분말이 접촉하게 되면 튀어나간 전자가 만든 전위가 통증부위의 전위보다 낮기 때문에 몸에 축적되어 있던 전자가 역전되어 줄어 들게 되고, 그 갯수가 점점 줄어들게 되면 통증이 완화되게 된다.For this reason, when the powder comes into contact with the pain area, the potential created by the protruding electrons is lower than that of the pain area, so that the electrons accumulated in the body are reversed and reduced, and when the number gradually decreases, the pain is relieved.
이때, 셀레늄이 보조적인 역할을 하게 되는데, 셀레늄은 특히 항산화 촉진에 기여하게 된다.At this time, selenium plays an auxiliary role, and selenium in particular contributes to promoting antioxidants.
아울러, 상기 홀뮴은 육세나이트로부터 이온교환 기법에 의해 얻은 산화홀뮴을 사용함이 바람직하고, 특히 피부 접촉시 인체 유해성분인 중금속은 흡착 제거하는 제거능이 뛰어나며, 세포 재생기능이 우수하다.In addition, as for the holmium, it is preferable to use holmium oxide obtained by an ion exchange technique from hexanite. In particular, it is excellent in adsorbing and removing heavy metals that are harmful to the human body when contacting the skin, and excellent cell regeneration function.
또한, 상기 지르코늄 분말은 활성산소를 제거하고 유해성분 제거를 위해 첨가되며; 상기 이트륨 분말은 심신안정, 진정기능 및 피부트러블 완화를 위해 첨가되고, 상기 마그네슘은 혈액청소(콜레스테롤 분해), 혈액순환 촉진, 경련 억제, 피로 회복, 감염예방을 위해 첨가된다.In addition, the zirconium powder is added to remove active oxygen and remove harmful components; The yttrium powder is added for mental and physical stability, soothing function and relief of skin problems, and the magnesium is added for blood cleaning (cholesterol degradation), promoting blood circulation, suppressing spasms, recovering from fatigue, and preventing infection.
다만, 이 파우더를 가축의 사료에 혼합하여 급여할 경우에는 미량으로 첨가해야 하므로 급여 기준에 맞춰 mg 단위로 첨가 사용하도록 하면 된다.However, if this powder is mixed with livestock feed, it must be added in trace amounts, so it is recommended to add and use in mg units according to the feeding standard.
그 외 가축 급여가 아닌 화장료에 사용할 경우에는 기능성에 맞춰 사용하면 되며, 본 발명은 그러한 기능성 화장료에 사용할 수 있도록 자체 특성을 갖는 파우더를 제공하는데 있다.In the case of using for cosmetics other than livestock feed, it can be used according to the functionality, and the present invention is to provide a powder having its own properties so that it can be used in such functional cosmetics.
특히, 본 발명에서는 특성 강화를 위해 바실러스균을 이용하여 자연숙성시킨다.In particular, in the present invention, the Bacillus bacteria are used for natural maturation in order to enhance properties.
뿐만 아니라, 게르마늄은 본 발명에 따른 파우더의 피부 침투, 혈액 침투능을 높여 혈액 정화, 혈액 순환 촉진에 기여하는 바가 크다.In addition, germanium greatly contributes to purifying blood and promoting blood circulation by increasing the skin penetration and blood penetration ability of the powder according to the present invention.
이에 더하여, 본 발명에서는 상기 페그마타이트 분말 100중량부에 대해, 잣 분말 10중량부와, DCHF-DA 분말 6.5중량부와, 케나프 추출물의 건조분말 8.5중량부를 더 첨가할 수 있다.In addition, in the present invention, with respect to 100 parts by weight of the pegmatite powder, 10 parts by weight of pine nut powder, 6.5 parts by weight of DCHF-DA powder, and 8.5 parts by weight of the dry powder of the kenaf extract may be further added.
이때, 상기 잣 분말은 잣에 다량 함유된 아연 성분에 의해 피부 흡수시 면역력을 급상승시키는 효과가 있는 것으로 보고되어 있다.At this time, it is reported that the pine nut powder has an effect of rapidly increasing immunity when absorbed by the skin due to the zinc component contained in a large amount of pine nuts.
또한, DCHF-DA(dichlorodihydrofluorescin diacetate) 분말은 비트(Beta vulgaris)에서 추출된 추출물을 건조시킨 후 분쇄한 것으로, 체내 세포의 항산화 특성을 강화시키는 작용을 하며, pH를 안정화시키게 된다.In addition, DCHF-DA (dichlorodihydrofluorescin diacetate) powder is pulverized after drying the extract extracted from beet (Beta vulgaris), it acts to enhance the antioxidant properties of cells in the body, and stabilizes the pH.
뿐만 아니라, 케나프 추출물의 건조분말은 인도, 방글라데시, 태국 등에서 재배되고 있는 양마(洋麻)의 잎과 줄기로부터 추출된 추출물을 건조시켜 얻은 분말로서, 칼슘이 우유의 4배 함유되어 있고, 다량의 단백질과 비타민 및 철분이 함유되어 있으며, 활성산소의 작용을 억제하는 항산화물질이 다량 함유되어 세포재생, 피부침착 억제 기능이 우수한 것으로 알려져 있다.In addition, the dry powder of Kenaf extract is a powder obtained by drying the extract extracted from the leaves and stems of Yangma grown in India, Bangladesh, and Thailand. It contains 4 times more calcium than milk and contains a large amount of calcium. It contains protein, vitamins, and iron, and contains a large amount of antioxidants that inhibit the action of free radicals, so it is known to have excellent functions of cell regeneration and skin adhesion inhibition.
이러한 조성을 포함하는 본 발명에 따른 파우더는 다음과 같이 제조된다.The powder according to the present invention containing such a composition is prepared as follows.
먼저, 치아시드 추출물의 건조분말을 제외한 나머지 파우더 조성물을 혼합하는 제1단계가 수행된다.First, a first step of mixing the powder composition other than the dry powder of the chia seed extract is performed.
이어, 혼합된 파우더 조성물에 바실러스 균액을 살포하고 상온(18-20℃)에서 48시간 자연숙성시키는 제2단계가 수행된다.Subsequently, a second step of spraying the Bacillus bacteria solution on the mixed powder composition and naturally aging at room temperature (18-20° C.) for 48 hours is performed.
상기 제2단계는 파우더 조성물의 특성강화 단계로서, 호기성미생물이 바실러스균이 발효시키는 과정에서 자연발생열에 의한 내부 반응에 의해 광물 특유의 특성들이 상보되면서 피부재생 및 진정기능 강화, 혈액순환 촉진 등의 특성들이 복합적으로 나타나는 것으로 추측된다.The second step is a step of enhancing the properties of the powder composition.In the process of fermenting Bacillus bacteria, aerobic microorganisms complement the peculiar properties of minerals by an internal reaction due to naturally generated heat, thereby enhancing skin regeneration and soothing functions, and promoting blood circulation. It is speculated that the characteristics appear complex.
특히, 치아시드 추출물을 첨가하지 않는 이유는 바실러스균을 사멸시키지 않도록 하기 위함이다.In particular, the reason why chia seed extract is not added is to avoid killing Bacillus bacteria.
아울러, 상기 제2단계에서 사용되는 바실러스 균액은 발효요건을 충족시킬 수 있도록 정제수 500ml를 기준으로 당밀 300g, 버섯추출액 50ml, 사탕수수액 50ml 혼합한 후 액체 배지에서 각각 배양된 바실러스균을 첨가한 다음 35℃에서 3일 동안 증식시켜 바실러스균이 1억개 이상/㎖ 유지되게 한 것을 사용해야 효과적이다.In addition, the Bacillus bacteria solution used in the second step was mixed with 300 g of molasses, 50 ml of mushroom extract, and 50 ml of sugarcane solution based on 500 ml of purified water to meet the fermentation requirements, and then Bacillus bacteria cultured in a liquid medium were added. It is effective to use one that has been grown at 35°C for 3 days to maintain more than 100 million Bacillus bacteria/ml.
이때, 당밀과 사탕수수액은 발효를 촉진하는 균류의 먹이이고, 버섯추출물은 페놀옥시다제(phenoloxidases)라는 효소가 다량 함유되어 있기 때문에 이 페놀옥시다제 효소에 의해 발효 과정에서 페놀을 세미퀴논을 거쳐 퀴논으로 이르게 하는 산화와, 퀴논과 아미노산류나 페푸치드류의 상호작용을 통해 부숙화가 촉진되면서 발효열을 60℃ 이상으로 높게 급격히 향상시킬 수 있는 효능이 있다.At this time, molasses and sugar cane are food for fungi that promote fermentation, and mushroom extract contains a large amount of an enzyme called phenoloxidases, so this phenol oxidase enzyme passes phenol through semiquinone in the fermentation process. It has the effect of rapidly improving the fermentation heat as high as 60°C or higher while promoting maturation through the oxidation leading to quinone and the interaction of quinone with amino acids or pepuccides.
이렇게 하여, 자연숙성이 완료되면 건조 살균하는 제3단계가 수행된다.In this way, when natural aging is completed, a third step of drying and sterilizing is performed.
상기 제3단계는 3eV의 전자선을 조사하여 남은 바실러스균을 완전히 살균하고, 동시에 건조하는 단계이다.The third step is a step of completely sterilizing the remaining Bacillus bacteria by irradiating an electron beam of 3 eV and drying at the same time.
이 단계를 거치면 먹이로 쓰였던 균액은 모조리 발효 분해된 상태이고, 건조된 상태이므로 본 발명이 목적하는 파우더만 남은 상태가 된다.After this step, all the bacteria liquids used as food are fermented and decomposed, and thus, only the powder for which the present invention is intended remains.
이 상태에서, 제1단계에서 배제시켰던 치아시드 추출물의 건조분말을 계량분만큼 첨가 혼합하는 제4단계를 수행함으로써 본 발명에 따른 파우더 제조를 완성하게 된다.In this state, the preparation of the powder according to the present invention is completed by performing a fourth step of adding and mixing the dry powder of the chia seed extract, which was excluded in the first step, as much as the measured amount.
이와 같이 제조된 파우더의 특성 확인을 위해 한국과학기술연구원의 중금속함유시험 기준에 따라 시험한 결과(KAS01H461) 중금속이 불검출되어 안전함을 확인하였다.As a result of testing according to the heavy metal content test standard of the Korea Institute of Science and Technology (KAS01H461) to confirm the properties of the powder thus prepared, it was confirmed that heavy metals were not detected and thus safe.
또한, 한국화학시험연구원의 시험기준에 따라 피부자극시험(TAK-001352), 안점막자극시험(TAK-029114), 피부감작성시험(TAK-029115), 급성경피독시험(TAK-029116)을 한 결과 모두 비자극 또는 무자극, 그리고 이상무로 확인되었다.In addition, skin irritation test (TAK-001352), eye mucosa irritation test (TAK-029114), skin sensitization test (TAK-029115), and acute dermal toxicity test (TAK-029116) were conducted in accordance with the test standards of the Korea Chemical Testing and Research Institute. As a result, all were identified as non-irritating or non-irritating and abnormal.
이를 통해, 안전하게 사용할 수 있음을 확인하였다.Through this, it was confirmed that it can be used safely.
뿐만 아니라, 혈액순환촉진 기능을 확인하기 위해 20명의 30대 여성을 선별하여 혈액순환측정기로 관능테스트 한 결과 피부에 바르기 전,후의 평균 심박수가 9회 정도 차이가 발생하였다.In addition, as a result of selecting 20 women in their 30s to check the function of promoting blood circulation and performing a sensory test with a blood circulation meter, the average heart rate before and after application to the skin was 9 times different.
이를 통해, 혈액순환 촉진기능이 있는 것으로 확인되었다.Through this, it was confirmed that it has a function of promoting blood circulation.
또한, 항균성을 확인하기 위해 본 발명 파우더에 곰팡이 균주를 떨어뜨린 후 20일간 항균 활성여부를 체크한 결과, 5일째 되는 날 곰팡이 균주수가 급격히 감소하더니 7일째 모두 사멸하였다.In addition, as a result of checking whether the fungal strain was dropped on the powder of the present invention for 20 days after dropping the fungal strain on the powder of the present invention, the number of fungal strains rapidly decreased on the 5th day and all died on the 7th day.
이를 통해, 항곰팡이성이 뛰어난 것으로 추론되었다.Through this, it was inferred that the anti-fungal property was excellent.
Claims (3)
치아시드 추출물의 건조분말을 제외한 나머지 파우더 조성물을 혼합하는 제1단계;
혼합된 파우더 조성물에 바실러스 균액을 살포하고 상온(18-20℃)에서 48시간 자연숙성시키는 제2단계;
자연숙성이 완료되면 3eV의 전자선을 조사하여 남은 바실러스균을 완전히 살균하고, 동시에 건조하는 제3단계;
제3단계 후, 상기 제1단계에서 배제시켰던 치아시드 추출물의 건조분말을 계량분만큼 첨가 혼합하는 제4단계;를 포함하는 것을 특징으로 하는 원적외선을 방출하는 파우더 제조방법.For 100 parts by weight of pegmatite powder having a particle size of 0.01-0.05 μm, 10 parts by weight of dry powder of chia seed extract, 5 parts by weight of germanium powder, 10 parts by weight of selenium powder, 3.5 parts by weight of zirconium powder, 4.0 parts by weight of yttrium powder, magnesium Containing 6.5 parts by weight of powder; In the powder manufacturing method for emitting far-infrared rays to which 10 parts by weight of pine nut powder, 6.5 parts by weight of DCHF-DA powder, and 8.5 parts by weight of dry powder of kenaf extract are further added to 100 parts by weight of the pegmatite powder;
A first step of mixing the remaining powder composition excluding the dry powder of chia seed extract;
A second step of spraying the Bacillus bacteria solution on the mixed powder composition and naturally aging for 48 hours at room temperature (18-20°C);
A third step of completely sterilizing the remaining Bacillus bacteria by irradiating an electron beam of 3 eV when natural aging is completed, and drying at the same time;
After the third step, a fourth step of adding and mixing the dry powder of the chia seed extract excluded in the first step as much as the measured amount; powder manufacturing method for emitting far-infrared rays, characterized in that it comprises a.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200047534A KR102167153B1 (en) | 2020-04-20 | 2020-04-20 | Powder manufacturing method that emits far-infrared rays |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200047534A KR102167153B1 (en) | 2020-04-20 | 2020-04-20 | Powder manufacturing method that emits far-infrared rays |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR102167153B1 true KR102167153B1 (en) | 2020-10-16 |
Family
ID=73035093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020200047534A KR102167153B1 (en) | 2020-04-20 | 2020-04-20 | Powder manufacturing method that emits far-infrared rays |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102167153B1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102554887B1 (en) * | 2022-10-06 | 2023-07-13 | 주식회사 미더스인터내셔날 | Method of adding additives for paints with light resistance and color development |
| KR102648858B1 (en) * | 2022-12-02 | 2024-03-20 | 주식회사 르봉뺑 | Method for manufacturing pine-nut cream and pine-nut cream manufactured by the same |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100366879B1 (en) | 2000-05-19 | 2003-01-09 | 김경미 | Manufacture method for circulation of the blood and powder |
| KR101124432B1 (en) * | 2009-01-13 | 2012-03-21 | 최재홍 | Traditional medicine cosmetic material contained germinated black bean and merhod of preparing the same |
| KR20120083956A (en) * | 2011-01-19 | 2012-07-27 | 김경미 | Method for producing powder |
| JP2013501778A (en) * | 2009-08-11 | 2013-01-17 | ヨン ジン キム | HEALTH SUPPLEMENTAL, FEED, PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THE SAME CONTAINING CHIASEED AND MACA |
| KR101803031B1 (en) | 2016-05-11 | 2017-11-29 | 박규섭 | A powder with excellent blood circulating increasing characteristics |
-
2020
- 2020-04-20 KR KR1020200047534A patent/KR102167153B1/en active IP Right Grant
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100366879B1 (en) | 2000-05-19 | 2003-01-09 | 김경미 | Manufacture method for circulation of the blood and powder |
| KR101124432B1 (en) * | 2009-01-13 | 2012-03-21 | 최재홍 | Traditional medicine cosmetic material contained germinated black bean and merhod of preparing the same |
| JP2013501778A (en) * | 2009-08-11 | 2013-01-17 | ヨン ジン キム | HEALTH SUPPLEMENTAL, FEED, PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THE SAME CONTAINING CHIASEED AND MACA |
| KR20120083956A (en) * | 2011-01-19 | 2012-07-27 | 김경미 | Method for producing powder |
| KR101803031B1 (en) | 2016-05-11 | 2017-11-29 | 박규섭 | A powder with excellent blood circulating increasing characteristics |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102554887B1 (en) * | 2022-10-06 | 2023-07-13 | 주식회사 미더스인터내셔날 | Method of adding additives for paints with light resistance and color development |
| KR102648858B1 (en) * | 2022-12-02 | 2024-03-20 | 주식회사 르봉뺑 | Method for manufacturing pine-nut cream and pine-nut cream manufactured by the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111407719B (en) | Skin barrier repair compound, face cream and preparation method thereof | |
| KR102167153B1 (en) | Powder manufacturing method that emits far-infrared rays | |
| KR20080070569A (en) | Atopy eczema relaxant composition using natural material | |
| CN102258209A (en) | Production process for Jerusalem artichoke beverage | |
| KR20150075598A (en) | A method for preparation of mixed composition with fermented medical plants extracts | |
| KR20130038018A (en) | Method for producing cosmetic beauty water comprising soluble silicate salt and cinnamomum camphora oil | |
| KR102014979B1 (en) | Mask pack with improved elasticity manufactured by using biodegradable polymer and loess, and the method for manufacturing the mask pack | |
| KR20210009110A (en) | Antimicrobial toothpaste composition containing mastic and myrrh | |
| KR101020535B1 (en) | The cosmetic composion prepared to the lotus fermented water | |
| KR102229482B1 (en) | Eryobotrya japonica leaf mineral sugar aging solution having a skin protecting effect and a method for producing the same | |
| KR20160143003A (en) | The extraction procedure for iceplant's active constituent | |
| KR102330277B1 (en) | Cosmetics composition comprising centella asiatica extracts | |
| KR100905437B1 (en) | Composition for treating of atopic dermatitis and preparing method thereof | |
| KR100952902B1 (en) | Make-up soap composition containing mature pine abstraction and preparing method thereof | |
| CN111450039A (en) | Mild and non-irritant moisturizing and anti-aging eye cream and preparation method thereof | |
| KR101955261B1 (en) | Cosmetic composition and method thereof | |
| KR102032116B1 (en) | Method for preparing tea fermented materials and cosmetic composition comprising the same | |
| CN1633981A (en) | Ion water beauty product and its face pack | |
| KR102448963B1 (en) | Manufacturing method of hypermineral ionized water, hypermineral ionized water manufactured by the same and cosmetic composition regarding skin cell comprising the same | |
| KR101814550B1 (en) | A Method for Preparing Bacterial Cellulose Using Scoria Extract and the Bacterial Cellulose Obtained Thereby | |
| KR101445689B1 (en) | Composition for Alleviating Atopic Dermatitis Comprising Mineral including microorganism and Natural enzyme | |
| CN111643416A (en) | Whitening and spot-fading mask and preparation method thereof | |
| KR102040245B1 (en) | Skin moisture and anti-aging cosmetic composition with the extract of Aloe Vera by Chojeong mineral water | |
| KR20160035722A (en) | A method for mucus acusta despecta sieboldiana feed live ore and cosmetic composition containing thereof | |
| KR100811594B1 (en) | Composites and preparation method of toothpsate containing sulfur salts produced the andes mountains |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AMND | Amendment | ||
| X091 | Application refused [patent] | ||
| AMND | Amendment | ||
| AMND | Amendment | ||
| X701 | Decision to grant (after re-examination) | ||
| GRNT | Written decision to grant |